"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Descriptor ID |
D015658
|
| MeSH Number(s) |
C02.782.815.616.400 C02.800.801.400 C20.673.480
|
| Concept/Terms |
HIV Infections- HIV Infections
- HIV Infection
- Infection, HIV
- Infections, HIV
- HTLV-III-LAV Infections
- HTLV III LAV Infections
- HTLV-III-LAV Infection
- Infection, HTLV-III-LAV
- Infections, HTLV-III-LAV
- T-Lymphotropic Virus Type III Infections, Human
- T Lymphotropic Virus Type III Infections, Human
- HTLV-III Infections
- HTLV III Infections
- HTLV-III Infection
- Infection, HTLV-III
- Infections, HTLV-III
HIV Coinfection- HIV Coinfection
- Coinfection, HIV
- Coinfections, HIV
- HIV Coinfections
|
Below are MeSH descriptors whose meaning is more general than "HIV Infections".
Below are MeSH descriptors whose meaning is more specific than "HIV Infections".
This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 1 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 3 | 3 | 6 |
| 1999 | 6 | 0 | 6 |
| 2000 | 8 | 1 | 9 |
| 2001 | 5 | 2 | 7 |
| 2002 | 8 | 1 | 9 |
| 2003 | 8 | 2 | 10 |
| 2004 | 9 | 0 | 9 |
| 2005 | 9 | 2 | 11 |
| 2006 | 8 | 1 | 9 |
| 2007 | 14 | 0 | 14 |
| 2008 | 11 | 5 | 16 |
| 2009 | 18 | 5 | 23 |
| 2010 | 14 | 2 | 16 |
| 2011 | 16 | 2 | 18 |
| 2012 | 24 | 0 | 24 |
| 2013 | 25 | 4 | 29 |
| 2014 | 23 | 4 | 27 |
| 2015 | 26 | 1 | 27 |
| 2016 | 39 | 6 | 45 |
| 2017 | 44 | 5 | 49 |
| 2018 | 46 | 3 | 49 |
| 2019 | 37 | 2 | 39 |
| 2020 | 52 | 4 | 56 |
| 2021 | 52 | 2 | 54 |
| 2022 | 49 | 0 | 49 |
| 2023 | 47 | 2 | 49 |
| 2024 | 43 | 2 | 45 |
| 2025 | 23 | 2 | 25 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Co-creation and evaluation of people-centered mobile health messages to promote PrEP adherence among GBMSM in China: a feasibility study. Sex Health. 2026 Apr 09; 23(2).
-
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China. Sex Health. 2026 Feb 05; 23(1).
-
HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder. J Clin Psychiatry. 2025 Dec 08; 87(1).
-
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic. J Antimicrob Chemother. 2025 Nov 04; 80(11):3092-3100.
-
Community-Based Organizations' Approaches to Recruitment and Retention for a Digital HIV Prevention Intervention for Young Men Who Have Sex With Men: A Mixed Methods Study. J Med Internet Res. 2025 Nov 03; 27:e63199.
-
Association Between Electronic Patient Portal Enrollment and HIV Care Outcomes Among People Living with HIV at an Urban Academic Medical Center. AIDS Behav. 2026 Jan; 30(1):315-318.
-
Development and preclinical evaluation of next-generation ?sigH-based live candidate vaccines. JCI Insight. 2025 Oct 08; 10(19).
-
Protocol for a randomized controlled trial of patient-portal-based screening for substance use among people with HIV. Front Public Health. 2025; 13:1583546.
-
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process. Lancet HIV. 2025 Sep; 12(9):e649-e659.
-
Preferences for Pre-Exposure Prophylaxis Implementation and Engagement in the HIV Pre-Exposure Prophylaxis Care Continuum Among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County. J Acquir Immune Defic Syndr. 2025 Aug 01; 99(4):349-358.